Curcumin attenuates lipopolysaccharide/D-galactosamine-induced acute liver injury by activating Nrf2 nuclear translocation and inhibiting NF-kB activation

Curcumin, a polyphenol in curry spice isolated from the rhizome of turmeric, has been reported to possess versatile biological properties including anti-inflammatory, anti-oxidant, antifibrotic, and anticancer activities. In this study, the hepatoprotective effect of curcumin was investigated in lipopolysaccharide (LPS)/D-galactosamine (D-GalN)-induced acute liver injury (ALI) in rats. Experimental ALI was induced with an intraperitoneal (ip) injection of sterile 0.9% sodium chloride (NaCl) solution containing 8 mu g LPS and 800 mg/kg D-GalN. Curcumin was administered once daily starting three days prior to LPS/D-GalN treatment. Results indicated that curcumin could attenuate hepatic pathological damage, decrease serum ALT and AST levels, and reduce malondialdehyde (MDA) content in experimental ALI rats. Moreover, higher dosages of curcumin pretreatment inhibited NF-kB activation and reduced serum TNF-alpha and liver TNF-alpha levels induced by LPS/D-GalN ip injection. Furthermore, we found that curcumin up-regulated the expression of nuclear Nrf2 and Nrf2-dependent antioxidant defense genes including heme oxygenase-1 (HO-1), glutamate-cysteine ligase (GCLC), NAD(P) H dehydrogenase, and quinone (NQO-1) in a dose-dependent manner. Our results showed that curcumin protected experimental animals against LPS/D-GalN-induced ALI through activation of Nrf2 nuclear translocation and inhibition of NF-kB activation. (C) 2017 Elsevier Masson SAS. All rights reserved.